Metabolic signatures and potential biomarkers for the diagnosis and treatment of colon cancer cachexia
Cancer cachexia (CAC) is a debilitating condition that often arises from noncachexia cancer (NCAC), with distinct metabolic characteristics and medical treatments. However, the metabolic changes and underlying molecular mechanisms during ca...
Main Authors: | Qiu Xu, Lu Ruohan, He Qiqing, Chen Shu, Huang Caihua, Lin Donghai |
---|---|
Format: | Article |
Language: | English |
Published: |
China Science Publishing & Media Ltd.
2023-09-01
|
Series: | Acta Biochimica et Biophysica Sinica |
Subjects: | |
Online Access: | https://www.sciengine.com/doi/10.3724/abbs.2023151 |
Similar Items
-
Metabolic Biomarkers for the Early Detection of Cancer Cachexia
by: Thomas M. O’Connell, et al.
Published: (2021-09-01) -
Biomarkers for Cancer Cachexia: A Mini Review
by: Zhipeng Cao, et al.
Published: (2021-04-01) -
Discovery of serum biomarkers for diagnosis of tuberculosis by NMR metabolomics including cross-validation with a second cohort
by: R. Conde, et al.
Published: (2022-08-01) -
Editorial: Metabolic Adaptation of Muscle Tissue in Diseases Associated With Cachexia
by: Federica Cirillo, et al.
Published: (2022-06-01) -
Metabolomics approach for discovering disease biomarkers and understanding metabolic pathway
by: Jeeyoun Jung, et al.
Published: (2011-12-01)